SCHEMBL21799808

SCHEMBL21799808

CC(C)(C)CNCCCCN

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.55
CA2 P00918 3/20 0.55
CA4 P22748 3/20 0.55
CA6 P23280 3/20 0.55
CA5A P35218 3/20 0.55
CA7 P43166 3/20 0.55
CA9 Q16790 3/20 0.55
CA14 Q9ULX7 3/20 0.55
CA5B Q9Y2D0 3/20 0.55
F13A1 P00488 2/20 0.55
CYP1A2 P05177 2/20 0.55
ALOX15 P16050 2/20 0.55
THPO P40225 2/20 0.55
CA3 P07451 2/20 0.55
CA1 P00915 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
TSHR P16473 1/20 0.55
MTOR P42345 1/20 0.55
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21367242 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799821 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799623 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799961 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799716 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799486 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799884 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL21799603 0.98 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL987305 0.92 CA12 (0.52) CA12CA2CA4CA6CA5A
SCHEMBL4116709 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3623398-B1 RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER ASAHI CHEMICAL IND (JP) 2024-08-28 EP disclosed
CN-110603273-B Modified block copolymer, method for producing modified block copolymer, and resin composition 旭化成株式会社 2022-10-14 CN disclosed
US-20220055997-A1 ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS COMPRISING SAME B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) 2022-02-24 US disclosed
US-11124593-B2 Modified block copolymer, method for producing modified block copolymer, and resin composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-09-21 US disclosed
US-20200199282-A1 Modified Block Copolymer, Method for Producing Modified Block Copolymer, and Resin Composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-06-25 US disclosed
EP-3623398-A1 MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2020-03-18 EP disclosed
CN-110603273-A Modified block copolymer, method for producing modified block copolymer, and resin composition 旭化成株式会社 2019-12-20 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220055997-A1 ANTIMICROBIAL COMPOUNDS AND COMPOSITIONS COMPRISING SAME MPO, IMMT, CLPP CA12 4377/4885CA2 4435/4885CA4 3798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.